Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chromatic Technologies is a private specialty-ink and smart-packaging company that develops responsive inks and coatings for consumer packaged goods, healthcare/pharma, and industrial applications. Its core technologies include thermochromic, photochromic, glow-in-the-dark, pressure/touch-responsive, and related encapsulated inks that change appearance in response to environmental stimuli. In healthcare and pharmaceutical packaging, the company markets printable sensing and authentication technologies for temperature monitoring, tamper indication, and cold-chain protection rather than therapeutics. Founded in 1993 from work originating in a Cornell lab, the company is headquartered in Colorado Springs, Colorado, exports globally, and operates an ISO 9001-certified production facility. Chromatic Technologies is best understood as a commercial-stage packaging materials and platform technology company with healthcare relevance, not as a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chromatic Technologies.